Upstream Bio Q3 EPS $(0.63) Beats $(0.76) Estimate, Sales $683.000K Beat $645.000K Estimate

Upstream Bio (NASDAQ: UPB) reported quarterly losses of $(0.63) per share which beat the analyst consensus estimate of $(0.76) by 17.54 percent. This is a 90.95 percent increase over losses of $(6.96) per share from the same period last year. The company reported quarterly sales of $683.000 thousand which beat the analyst consensus estimate of $645.000 thousand by 5.89 percent. This is a 12.52 percent increase over sales of $607.000 thousand the same period last year.